ACC: Niacin/Laropiprant no benefit in vascular disease
(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious side effects, according ...
Mar 12, 2013
0
0